Total Laparoscopic Versus Laparoscopic Assisted Left-sided Colon Cancer Resection

September 20, 2020 updated by: Dong Yang, Jilin University

Total Laparoscopic Versus Laparoscopic Assisted Left-sided Colon Cancer Resection:A Prospective, Multicenter, Randomized Controlled, Non Inferior Clinical Trial

The comparison between total laparoscopic and laparoscopic assisted left hemicolon cancer resection underwent to choose a more effective and safe operation.

Study Overview

Detailed Description

This is a prospective randomized controlled trial. It is estimated that the recruitment time is 24 months and the number of cases is 354 in total. The cases in the experimental group and the control group are allocated according to the proportion of 1:1. The perioperative recovery data, complications and oncology index of total laparoscopic and laparoscopic assisted operation would be compared.

Study Type

Interventional

Enrollment (Anticipated)

354

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Dong Yang, doctor

Study Locations

    • Ji Lin
      • Changchun, Ji Lin, China, 130021
        • Recruiting
        • The First Hospital of Jilin University
        • Contact:
          • Quan Wang, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • left sided cancer was defined as a tumour located in the distal third of transverse colon, in the left colonic angle, in the proximal descending colon, or the upper sigmoid colon(cT1-cT4a).
  • underwent total laparoscopic or laparoscopic assisted left-sided cancer resection

Exclusion Criteria:

  • have simultaneously other cancer

    • have severe systemic inflammatory disease ,serious illness such as diabetes, chronic lung diseases
    • the period is too late or the tumor is too large to carry on a total laparoscopic or laparoscopic assisted left-sided cancer resection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: laparoscopic assisted left colectomy
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard. lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion. The patients in the control group underwent with the traditional laparoscopic assisted technology. The free colon was taken out through a small incision in the middle of the abdomen or the outer edge of the left rectus abdominis. The mesentery was trimmed, the specimens were removed, and the anastomosis was completed.After the anastomosis, the whole surgical area was flushed and drainage tubes were left.
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard. lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion. The patients in the control group underwent with the traditional laparoscopic assisted technology. The free colon was taken out through a small incision in the middle of the abdomen or the outer edge of the left rectus abdominis. The mesentery was trimmed, the specimens were removed, and the anastomosis was completed. After the anastomosis, the whole surgical area was flushed and drainage tubes were left.
Experimental: total laparoscopic left colectomy
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard. lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion.In the experimental group, the mesentery was endoscopically trimmed, the specimens were excised and the anastomosis was completed under the laparoscope. The specimens were taken out through trocar incision in the navel or in the right lower abdomen. After the anastomosis, the whole surgical area was flushed and drainage tubes were left.
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard. lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion. In the experimental group, the mesentery was endoscopically trimmed, the specimens were excised and the anastomosis was completed under the laparoscope. The specimens were taken out through trocar incision in the navel or in the right lower abdomen. After the anastomosis, all surgical area was flushed and drainage tubes were left.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surgical site infection,SSI
Time Frame: one month after surgery
The primary outcome was the incidence of SSI based on the definitions of CDC guidelines: superficial incisional, deep incisional, and organ/space infections . Infections involving both organ/space and the incisional site (superficial or deep) were categorized as organ/space infections. Surgeons and nurses assessed the presence of infection daily during hospitalization. After hospital discharge, all patients were followed up until 30 days after surgery at outpatient clinics to check the wound.
one month after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the blood loss
Time Frame: one hour after surgery
the mount of blood loss during the whole operation
one hour after surgery
the operating time
Time Frame: one hour after surgery
the length between the beginning and the end of the whole operation
one hour after surgery
the incidence of complications
Time Frame: one month after surgery
one month after surgery
the conversive rate
Time Frame: one hour after surgery
one hour after surgery
Surgical resection quality
Time Frame: one hour after surgery
according to the CME (complete mesocolic excision,CME) evaluation criteria
one hour after surgery
number of lymphnodes dissected
Time Frame: one week after surgery
one week after surgery
first defecation time
Time Frame: one week after surgery
one week after surgery
the incision length
Time Frame: one week after surgery
one week after surgery
Visual Analogue Scale/Score (VAS)
Time Frame: one day after surgery
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.For example, the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain ( from 0 to 10)
one day after surgery
3-year DFS (Disease-free survival)
Time Frame: three years after the operation
three years after the operation
5-year OS (overall survival)
Time Frame: five years after the operation
five years after the operation
first time for fluid diet
Time Frame: one week after surgery
one week after surgery
hospital stay
Time Frame: one month after surgery
one month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2020

Primary Completion (Anticipated)

December 20, 2021

Study Completion (Anticipated)

December 20, 2026

Study Registration Dates

First Submitted

December 12, 2019

First Submitted That Met QC Criteria

December 14, 2019

First Posted (Actual)

December 17, 2019

Study Record Updates

Last Update Posted (Actual)

September 22, 2020

Last Update Submitted That Met QC Criteria

September 20, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Cancer

Clinical Trials on laparoscopic assisted left colectomy

3
Subscribe